Kintara Announces Grant from Luxembourg National Research Fund and Cancer Foundation Luxembourg to Support VAL-083's Mechanism of Action Research in Glioblastoma Jan 12, 2022
Kintara Therapeutics to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference Jan 5, 2022
Kintara Therapeutics to Present at the MedInvest Oncology Investor Conference on December 9, 2021 Dec 7, 2021
Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma Nov 30, 2021
Kintara Presents Updates on Two Phase 2 Clinical Studies at the 2021 Society for Neuro-oncology Annual Meeting Nov 18, 2021
Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results and Provides Corporate Update Nov 15, 2021
Kintara Therapeutics to Present at the Q4 Investor Summit Virtual Conference on November 17, 2021 Nov 11, 2021
Kintara Therapeutics Announces Fiscal Year 2021 Financial Results and Provides Corporate Update Sep 29, 2021
